Receptor basis for dopaminergic supersensitivity in Parkinson's disease.
D000328:Adult; D000368:Aged; D001058:Apomorphine / Q000378:metabolism; D002421:Caudate Nucleus / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism; D006220:Haloperidol / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology*; D011699:Putamen / Q000503:physiopathology*; D011954:Receptors, Dopamine / Q000502:physiology*; D013570:Synaptic Membranes / Q000378:metabolism
D011954:Receptors, Dopamine; D007980:Levodopa; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine; D006719:Homovanillic Acid